4.7 Article

Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma - A case-matched comparison

Journal

RADIOTHERAPY AND ONCOLOGY
Volume 115, Issue 3, Pages 399-406

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2015.04.024

Keywords

Nasopharyngeal carcinoma; Recurrent; Radiotherapy; Surgery; Quality of life

Funding

  1. Program for New Century Excellent Talents in University - China [NCET-12-0562]
  2. Sun Yat-Sen University Clinical Research 5010 Program [201310]
  3. Guangdong Provincial Natural Science Foundation of China [S2013020012726]
  4. National High Technology Research and Development Program of China (863 Program) [2012AA02A501]

Ask authors/readers for more resources

Background: Salvage ENPG and IMRT are more effective treatments for rNPC than traditional 2-dimensional radiotherapy. However, compared with IMRT, the benefits of ENPG have not yet been clearly described. Methods: We defined a resectable area in which the disease could be radically removed using ENPG and our imaging specialists selected eligible patients with tumors confined to this resectable area from a database of rNPC patients. Using propensity scores to adjust for some potential prognostic factors, a well-balanced cohort of 144 limited rNPC patients was created by matching each patient who underwent ENPG (study group) with one who underwent IMRT (control group). Morbidity, long-term oncological results, treatment-related complications, medical costs, and quality of life were compared. Results: Compared with IMRT, ENPG was associated with a relatively good overall survival (5-year OS, 77.1% vs 55.5%, P = .003), QOL conservation (mean global health status score, 57.6 vs 29.8, P < .001), and significant decreases in post-treatment complications (12.5% vs 65.3%, P < .001), medical costs (23 645.90 vs 118 122.53 Yuan, P < .001) approximate to ((sic)2371.71 vs 11,847.80, P < .001). Conclusions: Salvage ENPG may be more effective for maximizing survival and QOL benefits and minimizing treatment-related complications and medical costs for limited rNPC patients, as compared with IMRT. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, Research & Experimental

Transoral Robotic Retropharyngeal Lymph Node Dissection in Nasopharyngeal Carcinoma With Retropharyngeal Lymph Node Recurrence

Xi Ding, Qing-Guang Lin, Xiong Zou, You-Ping Liu, Yi-Jun Hua, Yu-Long Xie, Zhi-Qiang Wang, Yi-Nuan Zhang, Yang-Kui Gu, Rui You, Qi Yang, Meng-Xia Zhang, Si-Yuan Chen, Yan-Feng Ouyang, Zi-Kun Yu, Rui Sun, Ming-Yuan Chen

Summary: TORS-RPLND is a feasible, safe, and effective method for treating NPC patients with RPLN recurrence, especially when combined with intraoperative ultrasound positioning. The procedure resulted in en bloc resection in 8 out of 10 patients, with mild complications and a low rate of recurrence.

LARYNGOSCOPE (2021)

Article Oncology

Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial

You-Ping Liu, Yi-Hui Wen, Jun Tang, Yi Wei, Rui You, Xiao-Lin Zhu, Jian Li, Lin Chen, Li Ling, Ning Zhang, Xiong Zou, Yi-Jun Hua, You-Mou Chen, Lei Chen, Li-Xia Lu, Ming-Yuan Chen, Wei-Ping Wen

Summary: Surgery significantly improved overall survival compared with IMRT in patients with resectable locally recurrent NPC. ENPG could be considered as the standard treatment option for this patient population, although long-term follow-up is needed to further determine the efficacy and toxicity of this strategy.

LANCET ONCOLOGY (2021)

Article Oncology

Metastatic characteristics associated with survival of synchronous metastatic nasopharyngeal carcinoma in non-epidemic areas

Mei Lin, Qi Yang, Rui You, Xiong Zou, Chong-yang Duan, You-ping Liu, Pei-yu Huang, Yu-long Xie, Zhi-qiang Wang, Ting Liu, Si-Yuan Chen, Yi-jun Hua, Ming-yuan Chen

Summary: This study analyzed the survival outcomes of nasopharyngeal carcinoma patients with metastasis and found that patients with bone and/or liver involvement tended to have lower survival rates, emphasizing the need for careful treatment selection.

ORAL ONCOLOGY (2021)

Article Oncology

The impact of induction chemotherapy on long-term quality of life in patients with locoregionally advanced nasopharyngeal carcinoma: Outcomes from a randomised phase 3 trial

Qi Yang, Le Xia, Mei Lin, Meng-Xia Zhang, Chong-Yang Duan, You-Ping Liu, Yu-Long Xie, Zhi-Qiang Wang, Rui You, Xiong Zou, Yi-Jun Hua, Pei-Yu Huang, Rui Sun, Ming-Huang Hong, Ming-Yuan Chen

Summary: This study confirmed that induction chemotherapy (IC) followed by concurrent chemo-radiotherapy (CCRT) had better long-term quality of life outcomes compared with CCRT alone in patients with locoregionally advanced nasopharyngeal carcinoma. The IC followed by CCRT group showed significantly improved results in role functioning, cognitive functioning, social functioning, fatigue, pain, and constipation, while showing poorer results in senses problems.

ORAL ONCOLOGY (2021)

Review Oncology

Surgical salvage of recurrent nasopharyngeal cancer- a multi-institutional review

Anna See, Clarisse Chu, Kimberley L. Kiong, Constance Teo, Hiang Khoon Tan, Eddy W. Y. Wong, Jason Y. K. Chan, Raymond K. Y. Tsang, Jimmy Chan, Kai-Ping Chang, Chih-Yen Chien, Sheng-Po Hao, Mingyuan Chen, Chwee Ming Lim

ORAL ONCOLOGY (2021)

Article Oncology

Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial

Yijun Hua, Rui You, Zhiqiang Wang, Peiyu Huang, Mei Lin, Yanfeng Ouyang, Yulong Xie, Xiong Zou, Youping Liu, Chongyang Duan, Yonglong Liu, Chenmei Gu, Rongzeng Liu, Qi Yang, Rou Jiang, Mengxia Zhang, Xi Ding, Siyuan Chen, Chao Lin, Rui Sun, Mingyuan Chen

Summary: The combination of toripalimab and IMRT was well-tolerated and showed promising antitumor activity in patients with recurrent nasopharyngeal carcinoma.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

Ling-Long Tang, Yu-Pei Chen, Chuan-Ben Chen, Ming-Yuan Chen, Nian-Yong Chen, Xiao-Zhong Chen, Xiao-Jing Du, Wen-Feng Fang, Mei Feng, Jin Gao, Fei Han, Xia He, Chao-Su Hu, De-sheng Hu, Guang-Yuan Hu, Hao Jiang, Wei Jiang, Feng Jin, Jin-Yi Lang, Jin-Gao Li, Shao-Jun Lin, Xu Liu, Qiu-Fang Liu, Lin Ma, Hai-Qiang Mai, Ji-Yong Qin, Liang-Fang Shen, Ying Sun, Pei-Guo Wang, Ren-Sheng Wang, Ruo-Zheng Wang, Xiao-Shen Wang, Ying Wang, Hui Wu, Yun-Fei Xia, Shao-Wen Xiao, Kun-Yu Yang, Jun-Lin Yi, Xiao-Dong Zhu, Jun Ma

Summary: The Chinese Society of Clinical Oncology (CSCO) formed a multidisciplinary team to develop comprehensive guidelines for the diagnosis and management of nasopharyngeal carcinoma (NPC) in order to improve the management of NPC.

CANCER COMMUNICATIONS (2021)

Article Oncology

Establishment of a patient-derived organoid model and living biobank for nasopharyngeal carcinoma

Xian-Wen Wang, Tian-Liang Xia, Hao-Cheng Tang, Xiong Liu, Ri Han, Xiong Zou, Yun-Teng Zhao, Ming-Yuan Chen, Gang Li

Summary: In this study, a living biobank using the NPCO model was successfully established, which has enormous potential in basic and clinical research on NPC.

ANNALS OF TRANSLATIONAL MEDICINE (2022)

Article Oncology

Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study

Xi Ding, Wei-Jing Zhang, Rui You, Xiong Zou, Zhi-Qiang Wang, Yan-Feng Ouyang, Lan Peng, You-Ping Liu, Chong-Yang Duan, Qi Yang, Chao Lin, Yu-Long Xie, Si-Yuan Chen, Yong-Long Liu, Chen-Mei Gu, Ruo-Qi Xie, Pei-Yu Huang, Ming-Huang Hong, Yi-Jun Hua, Ming-Yuan Chen

Summary: This study investigated the activity and safety of combining immune checkpoint inhibitors and antiangiogenic therapy for recurrent/metastatic nasopharyngeal carcinoma. The results showed promising antitumor activity with camrelizumab plus apatinib in refractory patients, but there were also treatment-related adverse events.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Medicine, General & Internal

Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Rui You, You -Ping Liu, Yu -Long Xie, Chao Lin, Chong -Yang Duan, Dong-Ping Chen, Yi Pan, Bin Qi, Xiong Zou, Ling Guo, Jing-Yu Cao, Yi-Nuan Zhang, Zhi-Qiang Wang, Yong -Long Liu, Yan-Feng Ouyang, Kai Wen, Qi Yang, Ruo-Qi Xie, Hui-Feng Li, Xiao-Tong Duan, Xi Ding, Lan Peng, Si -Yuan Chen, Jiong-Lin Liang, Zheng-Kai Feng, Tian-Liang Xia, Rui-Ling Xie, Rou Jiang, Chen-Mei Gu, Rong-Zeng Liu, Rui Sun, Xin Yang, Li-Zhi Liu, Li Ling, Qing Liu, Wai Tong Ng, Yi-Jun Hua, Pei-Yu Huang, Ming-Yuan Chen

Summary: This study compared the efficacy and safety of hyperfractionation with standard fractionation in intensity-modulated radiotherapy. The results showed that hyperfractionation significantly reduced the incidence of severe late complications and improved overall survival, suggesting that it could be used as the standard of care for patients with locally advanced recurrent nasopharyngeal carcinoma.

LANCET (2023)

Article Oncology

Concurrent chemotherapy using taxane plus cisplatin versus cisplatin alone in high-risk nasopharyngeal carcinoma patients with suboptimal response to induction chemotherapy

Ya-Ni Zhang, Yu-Pei Chen, Ji-Bin Li, Tai-Xiang Lu, Fei Han, Chun-Yan Chen

Summary: The study aimed to compare the efficacy and safety of concurrent chemotherapy using taxane plus cisplatin with cisplatin alone in high-risk LANPC patients. The objective response rate of the taxane plus cisplatin group was marginally higher than the cisplatin alone group, but not significant. There was no superiority in long-term survival for the taxane plus cisplatin group. However, the taxane plus cisplatin group had a significantly higher incidence of hematological toxicities.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2023)

Article Oncology

BCL6-SPECC1L: A Novel Fusion Gene in Nasopharyngeal Carcinoma

Shuo-Gui Fang, Tian-Liang Xia, Jian-Chang Fu, Tong Li, Qian Zhong, Fei Han

Summary: This study identified a novel fusion gene, BS, in nasopharyngeal carcinoma (NPC), which may play an important role in the occurrence and development of this cancer. The presence of the BS fusion gene was found to be relatively low in NPC tissues, but the altered localization and transcriptional inhibitory function of the BCL6 protein as a result of the fusion may contribute to the development of NPC.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2022)

Article Medicine, Research & Experimental

Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinoma

Rui You, Xiong Zou, Xi Ding, Wei-Jing Zhang, Meng-Xia Zhang, Xiao Wang, Han-Shi Xu, Yong-Long Liu, Yan-Feng Ouyang, Chong-Yang Duan, Chen-Mei Gu, Zhi-Qiang Wang, You-Ping Liu, Yi-Jun Hua, Pei Yu Huang, Ming-Yuan Chen

Summary: This study investigated the efficacy and safety of gemcitabine plus apatinib and toripalimab in RM-NPC, and found that this triple combination therapy exhibited promising antitumor activity and manageable toxicities. Patients with repeated radiotherapy and an interval of less than 12 months from the last radiotherapy should be carefully selected for antiangiogenic therapies.
Article Oncology

Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study

Meng-Xia Zhang, Ting Liu, Rui You, Xiong Zou, Yong-Long Liu, Xi Ding, Chong-Yang Duan, Han-Shi Xu, You-Ping Liu, Rou Jiang, Zhi-Qiang Wang, Chao Lin, Yu-Long Xie, Si-Yuan Chen, Yan-Feng Ouyang, Ruo-Qi Xie, Yi-Jun Hua, Rui Sun, Pei-Yu Huang, Shun-Lan Wang, Ming-Yuan Chen

Summary: The study found that local therapy directed at liver and lung metastases from nasopharyngeal carcinoma can improve overall survival rates for patients, with a more significant benefit seen in liver and lung metastases. However, the survival benefits of local therapy for bone metastases were not as prominent, and a biological effective dose greater than 60 Gy was found to yield more survival benefit in these cases.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)

Article Oncology

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group

Derek A. Mumaw, Allison J. Hazy, Aleksander Vayntraub, Thomas J. Quinn, Kamran Salari, John H. Chang, Noah Kalman, Sanford Katz, James Urbanic, Robert H. Press, Arpi Thukral, Henry Tsai, George E. Laramore, Jason Molitoris, Carlos Vargas, Samir H. Patel, Craig Stevens, Rohan L. Deraniyagala

Summary: This study evaluated contralateral recurrences in patients with oropharyngeal squamous cell carcinoma who received unilateral proton beam therapy. The results showed a favorable contralateral neck failure rate that was comparable to photon irradiation.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis

Kangpyo Kim, Dongryul Oh, Jae Myoung Noh, Yang Won Min, Hong Kwan Kim, Yong Chan Ahn

Summary: This study suggests that hypofractionated radiation therapy alone is a feasible option for early stage esophageal squamous cell carcinoma patients. Particularly, in patients with tumor length < 3 cm, this treatment scheme shows favorable local control rates with low incidence of esophageal toxicities.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy

Lin Chen, Jing Li, Kunpeng Li, Jiang Hu, Qingjie Li, Chenglong Huang, Gaoyuan Wang, Na Liu, Linglong Tang

Summary: This study analyzed the probability of hearing impairment after radiotherapy for nasopharyngeal carcinoma and developed a predictive model, providing dose limitation suggestions to improve patients' quality of life.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

FLASH radiotherapy using high-energy X-rays: Current status of PARTER platform in FLASH research

Yiwei Yang, Jianxin Wang, Feng Gao, Zhen Liu, Tangzhi Dai, Haowen Zhang, Hongyu Zhu, Tingting Wang, Dexin Xiao, Kui Zhou, Zheng Zhou, Dai Wu, Xiaobo Du, Sen Bai

Summary: This paper provides a comprehensive description of the current status of PARTER, which is the first experimental FLASH platform utilizing megavoltage X-rays. It showcases the reliable performance and stability of the dosimeters and monitors used in PARTER, as well as the satisfactory dose distribution and characteristics of the FLASH X-rays. The platform effectively meets the requirements of preclinical research on megavoltage X-ray FLASH and undergoes continuous upgrades.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation

Maria Thor, Kelly Fitzgerald, Aditya Apte, Jung Hun Oh, Aditi Iyer, Otasowie Odiase, Saad Nadeem, Ellen D. Yorke, Jamie Chaft, Abraham J. Wu, Michael Offin, Charles B. Simone Ii, Isabel Preeshagul, Daphna Y. Gelblum, Daniel Gomez, Joseph O. Deasy, Andreas Rimner

Summary: The purpose of this study was to identify predictors of disease progression in early-stage non-small cell lung cancer (NSCLC) patients after receiving definitive stereotactic body radiation therapy (SBRT). The results showed that tumor diameter and SUVmax were the most frequently reported features associated with progression/survival, and a re-fitted model including these two features had the best performance.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma

Yong-Qiao He, Tong-Min Wang, Da-Wei Yang, Wen-Qiong Xue, Chang-Mi Deng, Dan-Hua Li, Wen-Li Zhang, Ying Liao, Ruo-Wen Xiao, Lu-Ting Luo, Hua Diao, Xia-Ting Tong, Yan-Xia Wu, Xue-Yin Chen, Jiang-Bo Zhang, Ting Zhou, Xi-Zhao Li, Pei-Fen Zhang, Xiao-Hui Zheng, Shao-Dan Zhang, Ye-Zhu Hu, Guan-Qun Zhou, Jun Ma, Ying Sun, Wei-Hua Jia

Summary: In this study, researchers aimed to establish a predictive model for radiation-induced brain injury (RBI) in nasopharyngeal carcinoma (NPC) patients by incorporating clinical factors and newly developed genetic variants. They conducted a large-scale retrospective study and a genome-wide association study to develop a polygenic risk score (PRS) for RBI risk prediction. The results showed that the PRS, combined with clinical factors, improved the accuracy of RBI risk stratification and suggested personalized radiotherapy.

RADIOTHERAPY AND ONCOLOGY (2024)

Review Oncology

Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): A systematic review

Xiaoyong Xiang, Zhe Ji, Jing Jin

Summary: A review of studies suggests that brachytherapy as a salvage therapy for recurrent glioblastoma shows acceptable safety and good post-treatment clinical efficacy for selected patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts

M. Berbee, C. T. Muijs, F. E. M. Voncken, L. Wee, M. Sosef, B. van Etten, J. W. van Sandick, F. A. R. M. Warmerdam, J. J. de Haan, E. Oldehinkel, J. M. van Dieren, L. Boersma, J. A. Langendijk, A. van der Schaaf, J. B. Reitsma, E. Schuit

Summary: This study externally validated a model for predicting 2-year total mortality in lung cancer patients in esophageal cancer patients. The intercept and/or slope of the original model needed adjustment to achieve good performance in esophageal cancer patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Nine years of plan of the day for cervical cancer: Plan library remains effective compared to fully online-adaptive techniques

Dominique Reijtenbagh, Jeremy Godart, Joan Penninkhof, Sandra Quint, Andras Zolnay, Jan-Willem Mens, Mischa Hoogeman

Summary: This study compared the performance of the current PotD strategy with non-adaptive and fully online-adaptive techniques in the treatment of cervical cancer patients. The findings show that the PotD protocol is effective in improving normal tissue sparing compared to no adaptation, while fully online-adaptive approaches can further reduce target volume but come with a more complex workflow.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Prediction of radiation pneumonitis using the effective α/β of lungs and heart in NSCLC patients treated with proton beam therapy

Albrecht Weiss, Steffen Loeck, Ting Xu, Zhongxing Liao, Aswin L. Hoffmann, Esther G. C. Troost

Summary: Traditional models for predicting radiation pneumonitis may not be applicable to non-small cell lung cancer patients treated with passively-scattered proton therapy. The use of effective alpha/beta parameter can predict the occurrence of radiation pneumonitis in these patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Primer shot fractionation with an early treatment break is theoretically superior to consecutive weekday fractionation schemes for early-stage non-small cell lung cancer

Z. A. R. Gouw, J. Jeong, A. Rimner, N. Y. Lee, A. Jackson, A. Fu, J-j. Sonke, J. O. Deasy

Summary: This study investigates the effectiveness of non-uniform fractionation schedules in radiotherapy for early-stage non-small cell lung cancer. Through modeling, optimized schedules are proposed to minimize local failures and toxicity risk. The results suggest that non-standard primer shot fractionation can reduce hypoxia-induced radioresistance and improve treatment outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity

Sara Ronchi, Alessandro Cicchetti, Maria Bonora, Rossana Ingargiola, Anna Maria Camarda, Stefania Russo, Sara Imparato, Paolo Castelnuovo, Ernesto Pasquini, Piero Nicolai, Mohssen Ansarin, Michele Del Vecchio, Marco Benazzo, Ester Orlandi, Barbara Vischioni

Summary: This study evaluates the efficacy and toxicity of carbon ion radiotherapy (CIRT) in locally advanced head and neck mucosal melanoma patients. The results show that CIRT is safe and effective in treating the local region, and immunotherapy after relapse can improve overall survival. However, further prospective trials are needed to assess the role of targeted/immune- systemic therapy in this disease.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

The rise of negative portrayals of radiation oncology: A textual analysis of media news

Dominik Wawrzuta, Justyna Klejdysz, Marzanna Chojnacka

Summary: This study analyzed articles about radiation oncology published in The New York Times since its inception in 1851, and identified changes in media sentiment and prevalent themes related to radiotherapy. The findings suggest an increasing negative sentiment in media coverage towards radiotherapy, with a shift towards reporting treatment errors, toxicity, and ineffectiveness.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses

Elaine Limkin, Pierre Blanchard, Benjamin Lacas, Jean Bourhis, Mahesh Parmar, Lisa Licitra, Quynh-Thu Le, Sue S. Yom, Catherine Fortpied, Johannes Langendijk, Jan B. Vermorken, Jacques Bernier, Jens Overgaard, Jonathan Harris, Jean-Pierre Pignon, Anne Auperin

Summary: This study investigated the impact of season of radiotherapy on the outcomes of head and neck squamous cell cancer patients. The results showed that the season of radiotherapy did not have any significant effect on patient outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)

Fabio L. Cury, Gustavo A. Viani, Andre G. Gouveia, Camila V. S. Freire, Gabriel de A. Grisi, Fabio Y. Moraes

Summary: In limb-sparing treatment of soft tissue sarcoma patients, a 5-day course of preoperative radiotherapy results in high local control and favorable R0 margins, with acceptable complication rates, particularly for patients receiving higher biological equivalent doses.

RADIOTHERAPY AND ONCOLOGY (2024)